Literature DB >> 10978499

Pathogenesis of liver fibrosis: role of oxidative stress.

G Poli1.   

Abstract

In the liver, the progressive accumulation of connective tissue, a complex and dynamic process termed fibrosis, represents a very frequent event following a repeated or chronic insult of sufficient intensity to trigger a "wound healing"-like reaction. The fibrotic process recognises the involvement of various cells and different factors in bringing about an excessive fibrogenesis with disruption of intercellular contacts and interactions and of extracellular matrix composition. However, Kupffer cells, together with recruited mononuclear cells, and hepatic stellate cells are by far the key-players in liver fibrosis. Their cross-talk is triggered and favoured by a series of chemical mediators, with a prominent role played by the transforming growth factor beta. Both expression and synthesis of this inflammatory and pro-fibrogenic cytokine are mainly modulated through redox-sensitive reactions. Further, involvement of reactive oxygen species and lipid peroxidation products can be clearly demonstrated in other fundamental events of hepatic fibrogenesis, like activation and effects of stellate cells, expression of metalloproteinases and of their specific inhibitors. The important outcome of such findings as regards the pathogenesis of liver fibrosis derives from the observation of a consistent and marked oxidative stress condition in many if not all chronic disease processes affecting hepatic tissue. Hence, reactive oxidant species likely contribute to both onset and progression of fibrosis as induced by alcohol, viruses, iron or copper overload, cholestasis, hepatic blood congestion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10978499     DOI: 10.1016/s0098-2997(00)00004-2

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  129 in total

Review 1.  Mechanisms and cell signaling in alcoholic liver disease.

Authors:  Juliane I Beier; Craig J McClain
Journal:  Biol Chem       Date:  2010-11       Impact factor: 3.915

Review 2.  Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis.

Authors:  Umberto Vespasiani-Gentilucci; Paolo Gallo; Antonio De Vincentis; Giovanni Galati; Antonio Picardi
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

3.  Capsule oxymatrine in treatment of hepatic fibrosis due to chronic viral hepatitis: a randomized, double blind, placebo-controlled, multicenter clinical study.

Authors:  Yi-Min Mao; Min-De Zeng; Lun-Gen Lu; Mo-Bin Wan; Cheng-Zhong Li; Cheng-Wei Chen; Qing-Chuen Fu; Ji-Yao Wang; Wei-Min She; Xiong Cai; Jun Ye; Xia-Qiu Zhou; Hui Wang; Shan-Ming Wu; Mei-Fang Tang; Jin-Shui Zhu; Wei-Xiong Chen; Hui-Quan Zhang
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

Review 4.  Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma.

Authors:  Jinah Choi; Nicole L B Corder; Bhargav Koduru; Yiyan Wang
Journal:  Free Radic Biol Med       Date:  2014-05-06       Impact factor: 7.376

5.  EW-7197 inhibits hepatic, renal, and pulmonary fibrosis by blocking TGF-β/Smad and ROS signaling.

Authors:  Sang-A Park; Min-Jin Kim; So-Yeon Park; Jung-Shin Kim; Seon-Joo Lee; Hyun Ae Woo; Dae-Kee Kim; Jeong-Seok Nam; Yhun Yhong Sheen
Journal:  Cell Mol Life Sci       Date:  2014-12-09       Impact factor: 9.261

6.  Liver cirrhosis as a consequence of iron overload caused by hereditary nonspherocytic hemolytic anemia.

Authors:  Philip Hilgard; Guido Gerken
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

7.  Effects of Danggui Buxue Decoction () on lipid peroxidation and MMP-2/9 activities of fibrotic liver in rats.

Authors:  Yuan Chen; Qian Chen; Jing Lu; Feng-hua Li; Yan-yan Tao; Cheng-hai Liu
Journal:  Chin J Integr Med       Date:  2010-01-18       Impact factor: 1.978

8.  TGFbeta1 expression in colonic mucosa: modulation by dietary lipids.

Authors:  Fiorella Biasi; Cinzia Mascia; Giuseppe Poli
Journal:  Genes Nutr       Date:  2007-09-27       Impact factor: 5.523

9.  Monitoring the Progression of Chronic Liver Damage in Rats Using [18F]PBR06.

Authors:  Shuo Huang; Chao Li; Jun Guo; Linlin Zhang; Shuqi Wu; Hui Wang; Sheng Liang
Journal:  Mol Imaging Biol       Date:  2019-08       Impact factor: 3.488

Review 10.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.